Statistics
Publications
12
Citations
971
H-Index
12
Active since
2006
Johannes Lutz is an author at CureVac (Germany) specializing in immunology, medicine, and cell biology.
Publications per year
2006–2022
12
12
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
Johannes Lutz, Sandra Lazzaro, Mohamed Habbeddine et al. · npj Vaccines · 2017 · 250 citations · Full text
Niklas Engels, Lars M. König, Christina Heemann et al. · Nature Immunology · 2009 · 170 citations · Full text
Signal Transduction, Class-switched B Cells, Adaptive Immune System +11
1–5 of 12